Description
- 按条文编号查找
- 按条文内容查找
- 按方剂名称查找
- 按方剂组成查找
- 收藏重点条目和方剂
- 笔记功能
- 复制条文
- 简体 繁体切换
本App仅供中医爱好者和从业者学习参考使用，具体使用谨遵明医。
内容校订需要精力和时间，如有遗漏欢迎留言评论。
- 按条文内容查找
- 按方剂名称查找
- 按方剂组成查找
- 收藏重点条目和方剂
- 笔记功能
- 复制条文
- 简体 繁体切换
本App仅供中医爱好者和从业者学习参考使用，具体使用谨遵明医。
内容校订需要精力和时间，如有遗漏欢迎留言评论。
Screenshots
伤寒论条阅 FAQ
-
Is 伤寒论条阅 free?
Yes, 伤寒论条阅 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 伤寒论条阅 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 伤寒论条阅 cost?
伤寒论条阅 is free.
-
What is 伤寒论条阅 revenue?
To get estimated revenue of 伤寒论条阅 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
伤寒论条阅 Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
1
|
|
Top Paid
|
|
23
|
|
Top Grossing
|
|
51
|
|
Top Paid
|
|
132
|
|
Top Paid
|
|
179
|
伤寒论条阅 Competitors
伤寒论条阅 Installs
Last 30 days
伤寒论条阅 Revenue
Last 30 days伤寒论条阅 Revenue and Downloads
Gain valuable insights into 伤寒论条阅 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
健 王
- Languages
- English
- Recent release
- 2.0.8 (3 months ago )
- Released on
- Apr 7, 2021 (3 years ago )
- Also available in
- China, United Arab Emirates, Argentina, Austria, Australia, Azerbaijan, Belgium, Ecuador, Hong Kong SAR China, Italy, Thailand, Türkiye, Taiwan
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.